Generalized myasthenia gravis (gMG) affects most patients through a handful of well-characterized neuromuscular junction ...

Decreased AChR-Ab titers correlated with improved myasthenia gravis symptoms, especially in ADL scores, within the first 3 months of treatment. The study found no baseline correlation between AChR ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Recently approved treatments for generalized myasthenia gravis (gMG), including complement and neonatal Fc receptor ...

The present study does not shed further light on the mechanism either of myasthenia gravis or of the influence of the thyroid gland upon it. A case of a surgically athyreotic patient with ...

ADCs vary in components and mechanisms, influencing outcomes and toxicity; targeting HER2 and exploring combinations are promising strategies. Recent phase 1 study of SHR-A2102 shows promising ...

State Key Laboratory of Heavy Oil Processing, College of Chemistry and Chemical Engineering, China University of Petroleum (East China), Qingdao 266580, China ...

These can include neuromuscular disorders such as myasthenia gravis and muscular dystrophy. Ambrose explains that right now, the diagnosis can only be confirmed with molecular genetic testing ...

To learn this, the researchers measured the effect of Vyvgart using a test called the Myasthenia Gravis-Specific Activities of Daily Living scale (MG-ADL), which shows how gMG affects daily ...

Background and purpose: Myasthenia gravis (MG) is characterized by fluctuating muscle weakness due to immune-mediated damage to acetylcholine receptors. Viral infections can exacerbate symptoms of ...